Status:
COMPLETED
Utility of Immediate Post Placental Insertion of Intrauterine Device During Cesarean Delivery
Lead Sponsor:
Taghreed Alhaidari
Collaborating Sponsors:
Elweyia Maternity Teaching Hospital
Conditions:
Contraception Behavior
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Iraq is a country that ranks 33rd around world population growth rate. Meanwhile it is one of the counties in the middle east with the highest fertility rate, In addition to the considerable number of...
Detailed Description
Setting and design: It is a single arm prospective clinical trial. That had been conducted at Al Elweyia Maternity Teaching Hospital and Al Hayat Private Hospital in Baghdad during the period from Se...
Eligibility Criteria
Inclusion
- Women who delivered by caesarean section whether elective or emergency, counseled for IUD insertion in pre- natal period or at the time of labour and who has the will and her husband to be engaged in the study.
Exclusion
- Women with positive test for STIs (e.g. gonorrhea or chlamydia) in this pregnancy.
- Uterine anomaly that was known to distort the uterine cavity; whether uterine fibroid or congenital uterine anomalies.
- Developed postpartum hemorrhage.
- Diagnosed chorioamnionitis, intrapartum fever, or ruptured membranes for greater than 24 hours prior to delivery.
- Placenta previa or accrete.
- Anemia during pregnancy (Hb \< 10 g/dl).
Key Trial Info
Start Date :
September 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2019
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04136613
Start Date
September 1 2015
End Date
June 1 2019
Last Update
January 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Al Kindy College of Medicine/ University of Baghdad
Baghdad, Iraq, 10096